EyePoint Pharmaceuticals (EYPT) Stock Research

EyePoint Pharmaceuticals

· EYPT

Dashboard

Financials

KPIs

Ratios

Transcripts

Valuation

Statistics

294.846 M

-4.39%

Over a week ago

Sirius XM upgraded, Toast downgraded: Wall Street's top analyst calls

+15

Sep 2, 9:54 AM

Video: Dell rises as AI demand drives 'blowout' quarter

Sep 2, 9:07 AM

EyePoint just downgraded at TD Cowen, here's why

EYPT

Sep 2, 5:48 AM

EyePoint price target lowered by $23 at Jones, here's why

EYPT

Aug 19, 4:21 AM

Norwegian Cruise downgrade, Duolingo upgraded: Wall Street's top analyst calls

+12

Aug 18, 9:37 AM

EyePoint just downgraded at Chardan, here's why

EYPT

Aug 18, 8:01 AM

EyePoint just downgraded at H.C. Wainwright, here's why

EYPT

Aug 18, 6:09 AM

EyePoint price target lowered by $18 at Citi, here's why

EYPT

Aug 18, 5:57 AM

EyePoint just downgraded at RBC Capital, here's why

EYPT

Aug 18, 4:30 AM

RBC Capital gets more bearish on EyePoint, downgrades shares

EYPT

Aug 17, 8:51 PM

What You Missed On Wall Street On Monday

+28

Aug 17, 4:27 PM

Clear Street sees less competition for Ocular after EyePoint miss

Aug 17, 4:20 PM

Laidlaw trims EyePoint target, still sees high chance of approval

EYPT

Aug 17, 3:40 PM

B. Riley views EyePoint study miss as positive for 4D Molecular

Aug 17, 2:15 PM

EyePoint price target lowered by $22 at Jefferies, here's why

EYPT

Aug 17, 12:35 PM

Midday Fly By: Equinor buys stake in Energy Center, Nvidia to invest $1.5B in SB

+29

Aug 17, 12:29 PM

JPMorgan gets more bearish on EyePoint, downgrades shares

EYPT

Aug 17, 11:54 AM

EyePoint just downgraded at Cantor Fitzgerald, here's why

EYPT

Aug 17, 9:29 AM

Morning Movers: EyePoint plummets following LUGANO trial results

Aug 17, 8:55 AM

EyePoint down 69% at $4.52 as Duravyu phase 3 study endpoint was not met

EYPT

Aug 17, 8:42 AM

EyePoint announces topline results from LUGANO trial

EYPT

Aug 17, 7:22 AM

EyePoint price target raised by $8 at Cantor Fitzgerald

EYPT

Aug 6, 8:11 AM

EyePoint price target lowered by $3 at H.C. Wainwright, here's why

EYPT

Aug 6, 6:17 AM

EyePoint reports Q2 EPS ($1.09), consensus (96c)

EYPT

Aug 5, 7:38 AM

Citi opens 'upside 90-day catalyst watch' on EyePoint into data

EYPT

Aug 5, 6:33 AM

Charts